Saved in:
Bibliographic Details
Main Authors: de Grauw, M. J. J., Scholten, E. Th., Smit, E. J., Rutten, M. J. C. M., Prokop, M., van Ginneken, B., Hering, A.
Format: Preprint
Published: 2024
Subjects:
Online Access:https://arxiv.org/abs/2406.05231
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866913399317725184
author de Grauw, M. J. J.
Scholten, E. Th.
Smit, E. J.
Rutten, M. J. C. M.
Prokop, M.
van Ginneken, B.
Hering, A.
author_facet de Grauw, M. J. J.
Scholten, E. Th.
Smit, E. J.
Rutten, M. J. C. M.
Prokop, M.
van Ginneken, B.
Hering, A.
contents Size measurements of tumor manifestations on follow-up CT examinations are crucial for evaluating treatment outcomes in cancer patients. Efficient lesion segmentation can speed up these radiological workflows. While numerous benchmarks and challenges address lesion segmentation in specific organs like the liver, kidneys, and lungs, the larger variety of lesion types encountered in clinical practice demands a more universal approach. To address this gap, we introduced the ULS23 benchmark for 3D universal lesion segmentation in chest-abdomen-pelvis CT examinations. The ULS23 training dataset contains 38,693 lesions across this region, including challenging pancreatic, colon and bone lesions. For evaluation purposes, we curated a dataset comprising 775 lesions from 284 patients. Each of these lesions was identified as a target lesion in a clinical context, ensuring diversity and clinical relevance within this dataset. The ULS23 benchmark is publicly accessible via uls23.grand-challenge.org, enabling researchers worldwide to assess the performance of their segmentation methods. Furthermore, we have developed and publicly released our baseline semi-supervised 3D lesion segmentation model. This model achieved an average Dice coefficient of 0.703 $\pm$ 0.240 on the challenge test set. We invite ongoing submissions to advance the development of future ULS models.
format Preprint
id arxiv_https___arxiv_org_abs_2406_05231
institution arXiv
publishDate 2024
record_format arxiv
spellingShingle The ULS23 Challenge: a Baseline Model and Benchmark Dataset for 3D Universal Lesion Segmentation in Computed Tomography
de Grauw, M. J. J.
Scholten, E. Th.
Smit, E. J.
Rutten, M. J. C. M.
Prokop, M.
van Ginneken, B.
Hering, A.
Image and Video Processing
Computer Vision and Pattern Recognition
Machine Learning
Size measurements of tumor manifestations on follow-up CT examinations are crucial for evaluating treatment outcomes in cancer patients. Efficient lesion segmentation can speed up these radiological workflows. While numerous benchmarks and challenges address lesion segmentation in specific organs like the liver, kidneys, and lungs, the larger variety of lesion types encountered in clinical practice demands a more universal approach. To address this gap, we introduced the ULS23 benchmark for 3D universal lesion segmentation in chest-abdomen-pelvis CT examinations. The ULS23 training dataset contains 38,693 lesions across this region, including challenging pancreatic, colon and bone lesions. For evaluation purposes, we curated a dataset comprising 775 lesions from 284 patients. Each of these lesions was identified as a target lesion in a clinical context, ensuring diversity and clinical relevance within this dataset. The ULS23 benchmark is publicly accessible via uls23.grand-challenge.org, enabling researchers worldwide to assess the performance of their segmentation methods. Furthermore, we have developed and publicly released our baseline semi-supervised 3D lesion segmentation model. This model achieved an average Dice coefficient of 0.703 $\pm$ 0.240 on the challenge test set. We invite ongoing submissions to advance the development of future ULS models.
title The ULS23 Challenge: a Baseline Model and Benchmark Dataset for 3D Universal Lesion Segmentation in Computed Tomography
topic Image and Video Processing
Computer Vision and Pattern Recognition
Machine Learning
url https://arxiv.org/abs/2406.05231